Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
暂无分享,去创建一个
T. Barbui | G. Rossi | P. Casula | R. Bassan | E. Pogliani | G. Corneo | T. Izzi | M. Vespignani | P. Coser | T. Lerede | G. Rossi | P. Fabris | G. Lambertenghi‐Deliliers | S. Morandi
[1] T. Barbui,et al. Preliminary Results of a Risk-Oriented Program for B-Lineage Adult Acute Lymphoblastic Leukemia (ALL): The Collaborative Italian Study 08/96 , 2001 .
[2] T. Barbui,et al. Induction‐consolidation with an idarubicin‐containing regimen, unpurged marrow autograft, and post‐graft chemotherapy in adult acute lymphoblastic leukaemia , 1999, British journal of haematology.
[3] J. Garcia-conde,et al. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology. , 1998, Haematologica.
[4] S. Richards,et al. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA , 1997, British journal of haematology.
[5] P. Sonneveld,et al. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Barbui,et al. Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs. , 1997, Leukemia & lymphoma.
[7] F. Mandelli,et al. The GIMEMA ALL 0183 trial: analysis of 10‐year follow‐up , 1996, British journal of haematology.
[8] E. Thiel,et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. , 1996, Blood.
[9] T. Barbui,et al. Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. , 1996, Haematologica.
[10] D. Blaise,et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. , 1995, Blood.
[11] R. Larson,et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. , 1995, Blood.
[12] X. Thomas,et al. Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia. , 1995, Annals of hematology.
[13] C. Gisselbrecht,et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] E. Thiel,et al. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. , 1993, Leukemia.
[15] D. Hoelzer. Therapy of acute lymphoblastic leukemia in adults. , 1992, Leukemia.
[16] A. Rohatiner,et al. Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period. , 1992, Leukemia.
[17] M. O'donnell,et al. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. , 1991, Blood.
[18] E. Henderson,et al. Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study. , 1991, Leukemia.
[19] E. Estey,et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] K.,et al. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. , 1989, Blood.
[21] M. Andreeff,et al. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C. Pui,et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Andreeff,et al. Acute lymphoblastic leukemia in adults. , 1985, Seminars in oncology.